ClinicalTrials.gg
Active, not recruitingNCT06141720Updated Oct 22, 2026

Feasibility of a Mindfulness Intervention for Endometriosis Surgery

An interventional study of pain education and mindfulness of pain introduction and intervention in Endometriosis, Pain and Mindfulness, sponsored by Milton S. Hershey Medical Center. Active, not recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Milton S. Hershey Medical Center · Not applicable, Interventional, and Health services research

Updated Oct 22, 2026Now Active, not recruitingPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 169 studies in Endometriosis with a site in United States — 38 open to participants now, 48 under way, 5 of them phase 3. Endometriosis · United States.

Planned enrollment
96th of 131
20 · median 60
Started
2024
with 10 others
No phase
39 of 169
12 open now
Primary completion
2027-01
later than 11 of 47 live
Registered
132nd of 169
by date
Lead sponsor
8 of 169
Milton S. Hershey Medical Center

Among the 169 studies in Endometriosis with a site in United States, this one is the 96th largest by planned enrollment of the 131 interventional ones that give a count, is one of 11 that started in 2024, is one of 39 with no phase, reaches primary completion later than 11 of the 47 other live ones, and was the 132nd registered.

Endometriosis

921 studies on the registry are indexed under Endometriosis; 267 are open to participants now.

Browse Endometriosis studies →

Open to participants now

38 of the 169 studies in Endometriosis with a site in United States are open now. Recruiting first, the newest first:

33 more — sign in →

All 38 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 178 Endometriosis studies recruiting now, 52 (29%) set no upper age limit and 124 (70%) stop at 75 or younger; 18 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 169 studies in Endometriosis with a site in United States, or all of them as a file.
02

Study summary

Endometriosis is a common cause of pelvic pain in women which has been historically under-studied and under-diagnosed. The goal of this research is to pilot-test the feasibility and acceptability of a manualized, single-session brief mindfulness-based intervention (BMBI) among participants with endometriosis-related chronic pelvic pain (ECPP) who undergo surgical treatment, and gather preliminary data necessary for future studies assessing BMBI's impact on outcomes in surgically-treated ECPP. This pilot study will enroll 10-20 adult participants with ECPP to receive either a BMBI adjunctive to treatment as usual (TAU; n=5-10) or education with TAU (n=5-10) prior to their ECPP surgery. The central hypothesis is the BMBI is feasible to deliver pre-operatively, acceptable to patients, and may help improve acute post-surgical outcomes through more adaptive stress coping and pain processing, enabled by mindfulness training.

03

Conditions studied

  • Endometriosis
  • Pain
  • Mindfulness
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. age 18 years or older
  2. diagnosis or probable diagnosis of endometriosis
  3. candidate for surgical procedure for endometriosis
  4. English speaking
  5. have access to wifi and email

Exclusion criteria

Exclusion Criteria:

  1. prior formal mindfulness training
  2. Unable to consent
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    Standard of care for endometriosis surgery plus education

    Behavioral: pain education

  • Experimental
    Standard of care for endometriosis surgery plus mindfulness

    Behavioral: mindfulness of pain introduction and intervention

Interventions

  • Behavioralpain education

    Pain education

  • Behavioralmindfulness of pain introduction and intervention

    Brief mindfulness of pain introduction and intervention

06

What researchers measure

Primary outcomes

  1. Use of opioid medication

    Morphine milligram equivalent following surgery

    Time frame: 1 week

  2. Use of opioid medication

    Morphine milligram equivalent following surgery

    Time frame: 3 months

  3. Pain intensity

    Numerical Pain Rating Scale 0-10, 10 being highest

    Time frame: 1 week

  4. Pain intensity

    Numerical Pain Rating Scale 0-10, 10 being highest

    Time frame: 3 months

Secondary outcomes

  1. Sleep quality (sleep duration, awakenings, efficiency)

    actigraphy monitoring

    Time frame: 1 week prior to surgery

  2. Sleep quality (sleep duration, awakenings, efficiency)

    actigraphy monitoring

    Time frame: 1 week following surgery

  3. Sleep report

    sleep diary (hours slept, activities during day and night)

    Time frame: 1 week following surgery

  4. Sleep report

    sleep diary (hours slept, activities during day and night)

    Time frame: 1 week prior to surgery

  5. Emotional functioning

    Hospital Anxiety and Depression Scale 0-21, 21 is worst

    Time frame: baseline

  6. Emotional functioning

    Hospital Anxiety and Depression Scale 0-21, 21 is worst

    Time frame: 1 week

  7. Emotional functioning

    Hospital Anxiety and Depression Scale 0-21, 21 is worst

    Time frame: 3 months

  8. Patient global impression of change

    Global Impression of change 1-7, 1 is best

    Time frame: 3 months

  9. Patient global impression of change

    Global Impression of change 1-7, 1 is best

    Time frame: 1 week

  10. Pain catastrophizing

    Pain catastrophizing Scale 0-52, 52 is worst

    Time frame: baseline

  11. Pain catastrophizing

    Pain catastrophizing Scale 0-52, 52 is worst

    Time frame: 1 week

  12. Pain catastrophizing

    Pain catastrophizing Scale 0-52, 52 is worst

    Time frame: 3 months

  13. Treatment satisfaction

    Treatment satisfaction 0-10, 10 being best

    Time frame: 1 week

  14. Treatment satisfaction

    Treatment satisfaction 0-10, 10 being best

    Time frame: 3 months

  15. Heart rate variability

    brief HRV assessment baseline and during intervention

    Time frame: baseline

Other outcomes

  1. Pain threshold

    Pain threshold

    Time frame: baseline

  2. Temporal summation

    Temporal summation of pain

    Time frame: baseline

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Jan 2027, 32 months after the start.

Of 198 non-industry interventional studies with no phase under Endometriosis, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 44. This study's planned 32 months is above that.

Counting every sponsor, half of 213 studies reached it within 25 months; a quarter within 13 and three quarters within 44.

Primary completion moved twice since we started tracking on Sep 25, 2026: Jun 2026 → Jan 2027, last on Oct 22, 2026.

Completion moved twice since we started tracking on Sep 25, 2026: Sep 2026 → Jan 2027, last on Oct 22, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 15, 2023
First posted
Nov 21, 2023
StartActual
May 30, 2024
Primary completionEst.
Jan 30, 2027was Jun 2026
CompletionEst.
Jan 30, 2027was Sep 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Oct 22, 2026
Primary completion
Jun 30, 2026→Jan 30, 2027
moved 2 times, Sep 29, 2026 – Oct 22, 2026
Study completion
Sep 30, 2026→Jan 30, 2027
moved 2 times, Sep 29, 2026 – Oct 22, 2026
Show all 2 updates
  1. Oct 22, 2026
    Recruiting→Active, not recruiting
    Primary completion Jun 30, 2027→Jan 30, 2027
    Study completion Sep 30, 2027→Jan 30, 2027
    + 3 other changes: verification date, contact details and site details
  2. Sep 29, 2026
    Primary completion Jun 30, 2026→Jun 30, 2027
    Study completion Sep 30, 2026→Sep 30, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06141720
Responsible party
Christa Coleman (Assistant Professor, Psychiatry and Behavioral Health, Milton S. Hershey Medical Center) — Principal investigator
First posted
Nov 21, 2023
Start date
May 30, 2024
Primary completion
Jan 30, 2027 (estimated)
Completion
Jan 30, 2027 (estimated)
Last update
Oct 22, 2026

Study contacts

Christa Coleman
principal investigator · Penn State Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion